Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
11 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
2Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Joined Alkermes in September 2025. Previously served as CFO of Omega Therapeutics and Aldeyra Therapeutics. Held various finance and operations positions at Bristol-Myers Squibb.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Scholar Rock Holding Corp

2021-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Scholar Rock Holding Corp

Open Scholar Rock Holding Corp profile →

Director at Scholar Rock Holding Corp

2021-01-01 → End not stated

current · source reported

Observed: 2026-09-25

Scholar Rock Holdi…Scholar Rock Holding CorpJoshua Reed

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingSRRK DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open sourceSource 2 · Sec FilingALKS DEF 14A executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Other Company Role, Technology background.Open sourceSource 3 · Sec FilingJNJ 10-K executive officersSupports Executive company, Executive title.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:joshua-reed
Record version
public-0

Published evidence records

7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. SRRK DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 11, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 18, 2026
    • Board role: Board role: Director · Claim reviewed: May 11, 2026
    • Committee assignments: Committee assignments: Audit, Nominating/Governance · Claim reviewed: May 11, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 18, 2026
    • Executive company: Executive at Alkermes, plc · Claim reviewed: May 18, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 11, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 18, 2026

  2. Scholar Rock Holding director board source

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  3. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 29, 2026

    Supports 1 claim
    • Professional Role: Director at Scholar Rock Holding Corp · Claim reviewed: May 18, 2026

  4. ALKS DEF 14A executive officers

    sec filing · Source published: Apr 6, 2026 · Retrieved: May 18, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 18, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 18, 2026
    • Executive company: Executive at Alkermes, plc · Claim reviewed: May 18, 2026
    • Executive title: Executive title: Senior Vice President, Chief Financial Officer · Claim reviewed: May 18, 2026
    • Other Company Role: Joshua Reed is also linked to Scholar Rock Holding Corporation as Board member. · Claim reviewed: May 18, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 18, 2026

  5. JNJ 10-K executive officers

    sec filing · Source published: Feb 11, 2026 · Retrieved: Apr 30, 2026

    Supports 2 claims
    • Executive company: Executive at Johnson & Johnson · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Executive Vice President, Innovative Medicine, R&D · Claim reviewed: May 3, 2026

  6. JNJ executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise reported in filings · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
    • Executive company: Executive at Johnson & Johnson · Claim reviewed: May 3, 2026
    • Executive function: Other Executive (EVP) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Executive Vice President, Innovative Medicine, R&D · Claim reviewed: May 3, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 18, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 18, 2026

AI expertise · Source reportedAI expertise reported in filings1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

AI governance relevance · Source reportedAI governance relevance reported from role and filings1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Source reportedIndependent director1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Scholar Rock HoldingSupported by 3 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · Source reportedBoard role: Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 11, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Audit, Nominating/Governance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 11, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 18, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 18, 2026

Executive company · CorroboratedExecutive at Alkermes, plcSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 18, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 18, 2026

Executive company · CorroboratedExecutive at Johnson & JohnsonSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 30, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive function · Source reportedOther Executive (EVP)1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: Chief Financial Officer1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 11, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

Executive title · CorroboratedExecutive title: Executive Vice President, Innovative Medicine, R&DSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 30, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: Senior Vice President, Chief Financial Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 18, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 18, 2026

Other Company Role · Source reportedJoshua Reed is also linked to Scholar Rock Holding Corporation as Board member.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 18, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 18, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 18, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 18, 2026

View all sources7 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  3. https://www.sec.gov/Archives/edgar/data/1727196/000110465926046917/tm261440-1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 29, 2026

    Supports: Director at Scholar Rock Holding Corp (NASDAQ: SRRK)

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 18, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 30, 2026

    Supports: Executive company · Executive title

  6. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: AI expertise · AI governance relevance · Executive company · Executive function · Executive title

  7. https://www.sec.gov/Archives/edgar/data/1727196/000110465926046917/tm261440-1_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership